BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 37916334)

  • 1. Predictive role of admission serum glucose, baseline NIHSS score, and fibrinogen on hemorrhagic transformation after intravenous thrombolysis with alteplase in acute ischemic stroke.
    Huang P; Yi XY
    Eur Rev Med Pharmacol Sci; 2023 Oct; 27(20):9710-9720. PubMed ID: 37916334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of admission serum glucose on the clinical prognosis of patients with acute ischemic stroke receiving alteplase intravenous thrombolysis.
    Huang P; Yi X
    Int J Immunopathol Pharmacol; 2023; 37():3946320231204597. PubMed ID: 37771034
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of intravenous thrombolysis in acute ischemic stroke patients with cerebral microbleeds and analysis of risk factors for hemorrhagic transformation.
    Lei YS; Li H; Lei JY; Li SX; Li DF
    Eur Rev Med Pharmacol Sci; 2022 Feb; 26(3):779-786. PubMed ID: 35179744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebral Microbleeds are an Independent Predictor of Hemorrhagic Transformation Following Intravenous Alteplase Administration in Acute Ischemic Stroke.
    Nagaraja N; Tasneem N; Shaban A; Dandapat S; Ahmed U; Policeni B; Olalde H; Shim H; Samaniego EA; Pieper C; Ortega-Gutierrez S; Leira EC; Adams HP
    J Stroke Cerebrovasc Dis; 2018 May; 27(5):1403-1411. PubMed ID: 29398533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemorrhagic risk factors after rt PA thrombolysis in acute cerebral infarction.
    Liu L; Luo GQ; Liu Q; Yang ZY
    Eur Rev Med Pharmacol Sci; 2023 Jun; 27(12):5542-5551. PubMed ID: 37401290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive model for the risk of hemorrhagic transformation after rt-PA intravenous thrombolysis in patients with acute ischemic stroke: A systematic review and meta-analysis.
    Zhong K; An X; Kong Y; Chen Z
    Clin Neurol Neurosurg; 2024 Apr; 239():108225. PubMed ID: 38479035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Impact of Discrepancy between Measured versus Stated Weight on Hemorrhagic Transformation and Clinical Outcomes after Intravenous Alteplase Thrombolysis.
    Shin DH; Kang MJ; Kim JW; Shin DJ; Park HM; Sung YH; Kim EY
    Cerebrovasc Dis; 2017; 44(5-6):241-247. PubMed ID: 28848080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Analysis of influencing factors of neurological function recovery and cerebral hemorrhage transformation after intravenous thrombolysis in patients with acute ischemic stroke].
    Chen Y; Zhang Q; You N; Wang L
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Nov; 32(11):1340-1345. PubMed ID: 33463494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous thrombolysis for mild stroke: NIHSS 3-5 Versus NIHSS 0-2.
    Wang L; Li G; Hao Y; Hao M; Xiong Y
    J Stroke Cerebrovasc Dis; 2023 May; 32(5):107070. PubMed ID: 36905743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous Thrombolysis is Effective in Mild Stroke Patients with an Admission NIHSS Score of 3 to 5.
    Zhang K; Han L
    Curr Neurovasc Res; 2023; 20(4):434-442. PubMed ID: 37909432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinants of 1-Year Unfavorable Outcomes of Intravenous Alteplase Thrombolysis for Acute Ischemic Stroke.
    Zhai M; Yang J; Cao X; Li Y; Xu H; Wang Y
    Clin Appl Thromb Hemost; 2023; 29():10760296231187616. PubMed ID: 37461226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Asymptomatic hemorrhage after thrombolysis may not be benign: prognosis by hemorrhage type in the Canadian alteplase for stroke effectiveness study registry.
    Dzialowski I; Pexman JH; Barber PA; Demchuk AM; Buchan AM; Hill MD;
    Stroke; 2007 Jan; 38(1):75-9. PubMed ID: 17122437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous Thrombolysis in Patients With White Matter Hyperintensities in the WAKE-UP Trial.
    Frey BM; Shenas F; Boutitie F; Cheng B; Cho TH; Ebinger M; Endres M; Fiebach JB; Fiehler J; Galinovic I; Barow E; Königsberg A; Schlemm E; Pedraza S; Lemmens R; Thijs V; Muir KW; Nighoghossian N; Simonsen CZ; Gerloff C; Thomalla G;
    Stroke; 2023 Jul; 54(7):1718-1725. PubMed ID: 37226772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive effects of S100β and CRP levels on hemorrhagic transformation in patients with AIS after intravenous thrombolysis: A concise review based on our center experience.
    Chen R; Jiang G; Liu Y; Pan H; Yan L; Zhao L; Zhao Y; Ji Q
    Medicine (Baltimore); 2023 Sep; 102(38):e35149. PubMed ID: 37747023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new nomogram for individualized prediction of the probability of hemorrhagic transformation after intravenous thrombolysis for ischemic stroke patients.
    Wu Y; Chen H; Liu X; Cai X; Kong Y; Wang H; Zhou Y; Zhu J; Zhang L; Fang Q; Li T
    BMC Neurol; 2020 Nov; 20(1):426. PubMed ID: 33234113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal impairment reduces the efficacy of thrombolytic therapy in acute ischemic stroke.
    Power A; Epstein D; Cohen D; Bathula R; Devine J; Kar A; Taube D; Duncan N; Ames D
    Cerebrovasc Dis; 2013; 35(1):45-52. PubMed ID: 23428996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrinogen decrease after intravenous thrombolysis in ischemic stroke patients is a risk factor for intracerebral hemorrhage.
    Vandelli L; Marietta M; Gambini M; Cavazzuti M; Trenti T; Cenci MA; Casoni F; Bigliardi G; Pentore R; Nichelli P; Zini A
    J Stroke Cerebrovasc Dis; 2015 Feb; 24(2):394-400. PubMed ID: 25497721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Different Dosages of Alteplase in Atrial Fibrillation-Related Acute Ischemic Stroke After Intravenous Thrombolysis: A Nationwide, Multicenter, Prospective Cohort Study in Taiwan.
    Lin SF; Chen CF; Hu HH; Ho BL; Chen CH; Chan L; Lin HJ; Sun Y; Lin YY; Chen PL; Lin SK; Wei CY; Lin YT; Lee JT; Chao AC;
    J Am Heart Assoc; 2022 Feb; 11(3):e023032. PubMed ID: 35048714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrinogen concentrate replacement in ischemic stroke patients after recombinant tissue plasminogen activator treatment.
    Vandelli L; Marietta M; Trenti T; Varani M; Bigliardi G; Rosafio F; Dell'acqua ML; Picchetto L; Nichelli P; Zini A
    Adv Clin Exp Med; 2019 Feb; 28(2):219-222. PubMed ID: 30507073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of FLAIR hyperintense lesions as imaging biomarkers to predict the outcome of acute stroke after intra-arterial thrombolysis following intravenous tissue plasminogen activator.
    Chung JW; Kim KJ; Noh WY; Jang MS; Yang MH; Han MK; Kwon OK; Jung C; Kim JH; Oh CW; Lee JS; Lee J; Bae HJ
    Cerebrovasc Dis; 2013; 35(5):461-8. PubMed ID: 23735898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.